tyrvaya
Tyrvaya (Varenicline Tartrate) is a cholinergic receptor agonist.
Varenicline Tartrate · by Oyster Point Pharma
Available as a generic: Varenicline Tartrate
Key facts
- Active ingredient
- Varenicline Tartrate
- Drug class
- Cholinergic Receptor Agonist
- Form
- Spray/Inhaler
- Strength
- Varenicline Tartrate EQ 0.03MG BASE/SPRAY
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Oyster Point Pharma
- What the pharmacy pays
- ~$12.08 for 30 — not your price
- FDA application
- NDA213978
What is Tyrvaya?
From the FDA label:TYRVAYA nasal spray contains varenicline which is a partial nicotinic acetylcholine receptor agonist of α4β2, α4α6β2, α3β4, and α3α5β4 receptors and a full α7 receptor agonist. Varenicline, as the tartrate salt, is a powder which is a white to off-white to slightly yellow solid whose chemical name is 7,8,9,10-tetrahydro-6,10-methano-6 H -pyrazino[2,3-h][3]benzazepine, (2 R ,3 R )-2,3-dihydroxybutanedioate (1:1). It is highly soluble in water. Varenicline tartrate has a molecular weight of 361.35 Daltons and a molecular formula of C 13 H 13 N 3 ⋅ C 4 H 6 O 6 . The chemical structure is: TYRVAYA (varenicline solution) nasal spray is formulated for intranasal use as a clear 0.6 mg/mL strength solution, at pH 6.4. After priming [see Dosage and Administration ( 2.2 )] , each actuation delivers a 0.05 mL spray containing 0.03 mg varenicline free base, equivalent to 0.05 mg of varenicline tartrate. The formulation also contains the following inactive ingredients: sodium phosphate dibasic heptahydrate, monobasic sodium phosphate anhydrous, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH) and water for injection. The chemical structure
How to use
One spray in each nostril twice daily (approximately 12 hours apart). ( 2.1 ) • Prime with seven (7) actuations before initial use. Re-prime with 1 actuation if not used for more than five (5) days. ( 2.2 ) 2.1 Dosing Information Spray TYRVAYA once in each nostril twice daily (approximately 12 hours apart). If a dose is missed, resume regular dosing at the next scheduled dose time. 2.2 Priming Instructions Priming : Prime TYRVAYA before initial use by pumping seven (7) actuations into the air away from the face. When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air. Do not shake.
Side effects
The most common adverse reaction reported in 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Oyster Point Pharma at 1-877-EYE-0123 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In three clinical studies of dry eye disease conducted with varenicline solution nasal spray, 349 patients received at least 1 dose of TYRVAYA. The majority of patients had 31 days of treatment exposure, with a maximum exposure of 105 days. The most common adverse reactions reported in 82% of TYRVAYA treated patients was sneezing. Other common adverse reactions that were reported in >5% of patients include cough (16%), throat irritation (13%), and instillation-site (nose) irritation (8%).
Who should not take Tyrvaya
None None.
Drug class
- Cholinergic Receptor Agonist
- Partial Cholinergic Nicotinic Agonist
How this class works, per Muscarinic Agonists - StatPearls - NCBI Bookshelf.
Dosage forms
Spray/Inhaler
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How does Tyrvaya work?
- Tyrvaya is a cholinergic receptor agonist. Cholinergic receptor agonists mimic acetylcholine and switch on its receptors, triggering the body's "rest and digest" responses. This boosts effects like saliva and tear flow, bladder and bowel emptying, and pupil constriction.
- How much does Tyrvaya cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $12.08 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Tyrvaya?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Tyrvaya. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Tyrvaya?
- Tyrvaya is marketed by Oyster Point Pharma. You can see Oyster Point Pharma's full profile, rating, and other products on pharmaranks.
- Is Tyrvaya a brand-name or generic drug?
- Tyrvaya is a brand-name product with the active ingredient Varenicline Tartrate. Lower-cost generic equivalents containing Varenicline Tartrate are available — ask your pharmacist.
- Is Tyrvaya available over the counter?
- No. Tyrvaya is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Tyrvaya come in?
- Tyrvaya is currently marketed as spray/inhaler, per the FDA's National Drug Code Directory.
- What class of drug is Tyrvaya?
- Tyrvaya is classified as cholinergic receptor agonist, partial cholinergic nicotinic agonist, per the FDA's Established Pharmacologic Class.
- Is Tyrvaya FDA-registered?
- Tyrvaya is on record with the U.S. FDA under application number NDA213978. You can verify this on its official FDA label.
- Is Tyrvaya safe?
- There's no single safe-or-not verdict, and we don't yet have a composite recall-safety score for Tyrvaya. Review its FDA-label side effects and warnings below, and always consult a licensed professional.
- What are the side effects of Tyrvaya?
- Tyrvaya's side effects are taken directly from its FDA label. From the label: The most common adverse reaction reported in 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation. ( 6 ) To report SUSPECTED ADVERSE REACTIONS,… Both common and serious reactions are documented in full on this page. This is general reference from the FDA, not medical advice — always consult a professional.
Clinical content sourced from the FDA label via openFDA (U.S. FDA). View the FDA label on DailyMed → Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
isopto carpine
Pilocarpine Hydrochloride
chantix
Varenicline Tartrate
miostat
Carbachol
pilocarpine hydrochloride
Pilocarpine Hydrochloride
qlosi
Pilocarpine Hydrochloride
salagen
Pilocarpine Hydrochloride
Compare Tyrvaya head-to-head
More cholinergic receptor agonist drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
tyrvaya
New